PTC Therapeutics (PTCT) Stock Price & Financial Analysis
PTC Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About PTC Therapeutics
What is the current stock price for PTCT?
As of the latest trading session, PTCT stock trades at $71.02. The 52-week range is $43.18–$87.50, with a day range of $70.47–$72.00.
What is the P/E ratio for PTCT?
PTC Therapeutics's trailing P/E ratio is 9.1, meaning investors pay $9.1 for every $1 of annual earnings. PTC Therapeutics operates in the Healthcare sector.
Does PTCT pay dividends?
PTC Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for PTCT?
Based on 5 analysts, the consensus for PTCT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of PTCT?
PTC Therapeutics's market capitalization is $6.27B, classifying it as a mid-cap company. PTC Therapeutics operates in the Healthcare sector within the Biotechnology industry.